Mwyngil Therapeutics Announces Updates On NLRP3 Portfolio
02 Feb 2026 //
PR NEWSWIRE
Brenig Announces Initiation of First-in-Human Study of BT-409
15 Jan 2026 //
PR NEWSWIRE
Mwyngil Acquires GPR75 Modulators From Expert Systems
06 Nov 2025 //
PR NEWSWIRE

Market Place
Sourcing Support